Pancreatic Cancer Research

ResearcherUniversity of LouisvilleNo recent work listed

Harshul Pandit

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0198-9303; OpenAlex author ID A5050660323. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 4

  1. Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cti2.1430↗
  2. Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-020-08782-2↗
  3. Evaluating the Regulatory Immunomodulation Effect of Irreversible Electroporation (IRE) in Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-018-07144-3↗
  4. Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/cgt.2015.46↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert C.G. Martin · 4 shared papers, 2015–2022 · strength 0.40
  2. Neal Bhutiani · 2 shared papers, 2020–2022 · strength 0.24
  3. Young Ki Hong · 2 shared papers, 2019–2022 · strength 0.24
  4. Yan Li · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.